Heartflow News
News
0
Ticker
HTFL
ISIN
US42238D1072
Heartflow Eulerpool News
Heartflow Stock News
Heartflow is being monitored by journalists and investors worldwide. We gather the latest Heartflow news here.
- November 3·Yahoo
- November 2·Benzinga
- October 20·Benzinga
- September 22·Benzinga
- September 17·Yahoo
- September 9·Benzinga
- February 15·SeekingAlpha
- January 29·Yahoo
- January 28·Benzinga
- January 10·Yahoo
- January 10·Yahoo
- January 5·Yahoo
- December 18·Benzinga
- November 30·Yahoo
- November 25·Yahoo
- November 20·SeekingAlpha
- November 12·SeekingAlpha
- November 10·Yahoo
- November 3·Benzinga
- October 23·Yahoo
Heartflow Stock Press Releases
Heartflow regularly publishes news on the company's website that are relevant for investors.
Heartflow News 2026
This page contains all current news, analysis and press releases for Heartflow stock (HTFL, ISIN: US42238D1072). This includes Eulerpool news, company analysis and official press releases. Data is updated regularly to provide investors with a complete overview of the latest developments at Heartflow.
Heartflow Stock
Heartflow Heartflow Inc generates revenue through its HeartFlow Platform, which includes AI-driven software solutions for diagnosing coronary artery disease. The company's products, such as HeartFlow FFRCT Analysis and Plaque Analysis, assist physicians in managing patient care by providing personalized 3D heart models derived from CCTA scans. These tools are sold to healthcare providers and hospitals, enabling non-invasive diagnosis and treatment planning for coronary artery disease. The RoadMap Analysis offers intuitive visualization of coronary arteries, helping physicians focus on critical areas during patient reviews. The HeartFlow Platform leverages artificial intelligence and computational fluid dynamics to create detailed cardiac models, positioning Heartflow Inc as a leader in medical technology for cardiovascular diagnostics. Its commercial-stage operations focus on delivering precision care solutions that improve diagnostic accuracy and patient outcomes. Healthcare institutions purchase these AI-powered tools to enhance their diagnostic capabilities without invasive procedures.